Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
transmembrane 7 superfamily member 2 | 0.486 | 0.808 | 1.4E-07 |
|
group | 0.100 | None | 0.950 | 20 | 0 | 2010 | 2020 | ||||||||
|
transmembrane 7 superfamily member 2 | 0.486 | 0.808 | 1.4E-07 |
|
group | 0.100 | None | 1.000 | 20 | 0 | 2001 | 2019 | ||||||||
|
transmembrane 7 superfamily member 2 | 0.486 | 0.808 | 1.4E-07 |
|
disease | 0.100 | None | 1.000 | 13 | 0 | 2011 | 2020 | ||||||||
|
transmembrane 7 superfamily member 2 | 0.486 | 0.808 | 1.4E-07 |
|
disease | 0.100 | None | 1.000 | 12 | 0 | 2003 | 2020 | ||||||||
|
transmembrane 7 superfamily member 2 | 0.486 | 0.808 | 1.4E-07 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2011 | 2020 | ||||||||
|
transmembrane 7 superfamily member 2 | 0.486 | 0.808 | 1.4E-07 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2011 | 2020 | ||||||||
|
transmembrane 7 superfamily member 2 | 0.486 | 0.808 | 1.4E-07 |
|
phenotype | 0.100 | None | 1.000 | 10 | 0 | 2001 | 2015 | ||||||||
|
transmembrane 7 superfamily member 2 | 0.486 | 0.808 | 1.4E-07 |
|
disease | 0.080 | None | 0.875 | 8 | 0 | 2003 | 2018 | ||||||||
|
transmembrane 7 superfamily member 2 | 0.486 | 0.808 | 1.4E-07 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2010 | 2019 | ||||||||
|
transmembrane 7 superfamily member 2 | 0.486 | 0.808 | 1.4E-07 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2000 | 2019 | ||||||||
|
transmembrane 7 superfamily member 2 | 0.486 | 0.808 | 1.4E-07 |
|
phenotype | 0.070 | None | 1.000 | 7 | 0 | 2015 | 2019 | ||||||||
|
transmembrane 7 superfamily member 2 | 0.486 | 0.808 | 1.4E-07 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2000 | 2019 | ||||||||
|
transmembrane 7 superfamily member 2 | 0.486 | 0.808 | 1.4E-07 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2009 | 2020 | ||||||||
|
transmembrane 7 superfamily member 2 | 0.486 | 0.808 | 1.4E-07 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 2004 | 2018 | ||||||||
|
transmembrane 7 superfamily member 2 | 0.486 | 0.808 | 1.4E-07 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2002 | 2012 | ||||||||
|
transmembrane 7 superfamily member 2 | 0.486 | 0.808 | 1.4E-07 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2017 | 2019 | ||||||||
|
transmembrane 7 superfamily member 2 | 0.486 | 0.808 | 1.4E-07 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2012 | 2019 | ||||||||
|
transmembrane 7 superfamily member 2 | 0.486 | 0.808 | 1.4E-07 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2004 | 2018 | ||||||||
|
transmembrane 7 superfamily member 2 | 0.486 | 0.808 | 1.4E-07 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2018 | 2019 | ||||||||
|
transmembrane 7 superfamily member 2 | 0.486 | 0.808 | 1.4E-07 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2014 | 2020 | ||||||||
|
transmembrane 7 superfamily member 2 | 0.486 | 0.808 | 1.4E-07 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2003 | 2017 | ||||||||
|
transmembrane 7 superfamily member 2 | 0.486 | 0.808 | 1.4E-07 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 2004 | 2016 | ||||||||
|
transmembrane 7 superfamily member 2 | 0.486 | 0.808 | 1.4E-07 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2013 | 2018 | ||||||||
|
transmembrane 7 superfamily member 2 | 0.486 | 0.808 | 1.4E-07 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1998 | 2019 | ||||||||
|
transmembrane 7 superfamily member 2 | 0.486 | 0.808 | 1.4E-07 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2017 | 2019 |